N. Coskun Et Al. , "Development and validation of a nomogram for predicting the likelihood of metastasis in prostate cancer patients undergoing Ga-68 PSMA PET/CT due to biochemical recurrence," Nuclear medicine communications , vol.43, no.8, pp.952-958, 2022
Coskun, N. Et Al. 2022. Development and validation of a nomogram for predicting the likelihood of metastasis in prostate cancer patients undergoing Ga-68 PSMA PET/CT due to biochemical recurrence. Nuclear medicine communications , vol.43, no.8 , 952-958.
Coskun, N., Kartal, M. O., Erdogan, A. S., & Ozdemir, E., (2022). Development and validation of a nomogram for predicting the likelihood of metastasis in prostate cancer patients undergoing Ga-68 PSMA PET/CT due to biochemical recurrence. Nuclear medicine communications , vol.43, no.8, 952-958.
Coskun, Nazim Et Al. "Development and validation of a nomogram for predicting the likelihood of metastasis in prostate cancer patients undergoing Ga-68 PSMA PET/CT due to biochemical recurrence," Nuclear medicine communications , vol.43, no.8, 952-958, 2022
Coskun, Nazim Et Al. "Development and validation of a nomogram for predicting the likelihood of metastasis in prostate cancer patients undergoing Ga-68 PSMA PET/CT due to biochemical recurrence." Nuclear medicine communications , vol.43, no.8, pp.952-958, 2022
Coskun, N. Et Al. (2022) . "Development and validation of a nomogram for predicting the likelihood of metastasis in prostate cancer patients undergoing Ga-68 PSMA PET/CT due to biochemical recurrence." Nuclear medicine communications , vol.43, no.8, pp.952-958.
@article{article, author={Nazim Coskun Et Al. }, title={Development and validation of a nomogram for predicting the likelihood of metastasis in prostate cancer patients undergoing Ga-68 PSMA PET/CT due to biochemical recurrence}, journal={Nuclear medicine communications}, year=2022, pages={952-958} }